Heme Oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion

被引:54
作者
Lo, Su-Shun
Lin, Shu-Chun
Wu, Chew-Wun
Chen, Jen-Hao
Yeh, Wen-I
Chung, Ming-Yi
Lui, Win-Yiu
机构
[1] Taipei Vet Gen Hosp, Div Gen Surg, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Med Educ & Res Dept, Taipei, Taiwan
关键词
gastric adenocarcinoma; heme oxygenase; heme oxygenase-1 promoter; polymorphism;
D O I
10.1245/s10434-006-9290-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Heme oxygenase-1 (HO-1) gene, which encodes an oxidative response protein, plays a role in cytoprotection. A (GT)(n) dinucleotide repeat in HO-1 promoter is polymorphic and modulates the transcriptional activity of the gene. A HO-1 gene promoter polymorphism was reported to be associated with the risks of lung adenocarcinoma and oral squamous cancer. In this study, the correlation between the HO-1 gene promoter polymorphism and the clinicopathological characteristics, along with the risk of gastric cancer, was analyzed. Experimental design: We examined the genotypic frequencies of (GT)(n) repeats in 183 gastric cancer patients and 250 control subjects by PCR-based genotyping and DNA sequencing. The length polymorphisms of (GT)(n) repeats were classified into short (S) component (n <= 25), medium (M) component (26 <= n <= 30) and long (L) component (n >= 31). The distribution of S, M and L components in patient and control groups were evaluated to determine the correlation with susceptibility and clinicopathological characteristics of gastric adenocarcinoma. Results: Higher frequencies of L-allele, L-allele carrier (S/L, M/L, L/L) and S/L genotype were found in gastric cancer patients. The frequencies of M-allele, M-allele carrier (M/M, M/L, M/S) and M/M genotype were significantly lower in patients with gastric cancer than controls. Furthermore, the frequency of lymphovascular tumor invasion was significantly lower in M-allele carriers compared to non-M-allele carriers (S/S, S/L, L/L) (P = 0.009). Conclusions: These findings suggest that the long (GT)(n) repeat of HO-1 gene promoter was associated with a higher frequency of gastric adenocarcinoma, and the medium (GT)(n) repeat might possess protective effect against gastric adenocarcinoma with a lower frequency of lymphovascular invasion in tumors.
引用
收藏
页码:2250 / 2256
页数:7
相关论文
共 50 条
[1]  
AGORESTI A, 1996, INTRO CATEGORICAL DA, P24
[2]   Fundamental role for HO-1 in the self-protection of renal allografts [J].
Baan, C ;
Peeters, A ;
Lemos, F ;
Uitterlinden, A ;
Doxiadis, I ;
Claas, F ;
Ijzermans, J ;
Roodnat, J ;
Weimar, W .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) :811-818
[3]  
BALLA G, 1992, J BIOL CHEM, V267, P18148
[4]  
BRUNE B, 1987, MOL PHARMACOL, V32, P497
[5]   Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers [J].
Chang, KW ;
Lee, TC ;
Yeh, WI ;
Chung, MY ;
Liu, CJ ;
Chi, LY ;
Lin, SC .
BRITISH JOURNAL OF CANCER, 2004, 91 (08) :1551-1555
[6]   Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients [J].
Chen, YH ;
Lin, SJ ;
Lin, MW ;
Tsai, HL ;
Kuo, SS ;
Chen, JW ;
Charng, MJ ;
Wu, TC ;
Chen, LC ;
Ding, PYA ;
Pan, WH ;
Jou, YS ;
Chau, LY .
HUMAN GENETICS, 2002, 111 (01) :1-8
[7]  
CORREA P, 1975, LANCET, V2, P58
[8]  
DELCORRAL MJC, 1990, CANCER, V65, P2078
[9]   The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage [J].
Denschlag, D ;
Marculescu, R ;
Unfried, G ;
Hefler, LA ;
Exner, M ;
Hashemi, A ;
Riener, EK ;
Keck, C ;
Tempfer, CB ;
Wagner, O .
MOLECULAR HUMAN REPRODUCTION, 2004, 10 (03) :211-214
[10]   Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth [J].
Doi, K ;
Akaike, T ;
Fujii, S ;
Tanaka, S ;
Ikebe, N ;
Beppu, T ;
Shibahara, S ;
Ogawa, M ;
Maeda, H .
BRITISH JOURNAL OF CANCER, 1999, 80 (12) :1945-1954